Latest News for: Novo Nordisk

Edit

Novo Nordisk A/S Sued for Securities Law Violations - Contact Levi & Korsinsky Before March ...

Longview News-Journal 28 Jan 2025
NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S ("Novo" or the "Company") (NYSE. NVO) of a class action securities lawsuit ....
Edit

US FDA approves Novo Nordisk's Ozempic to reduce diabetic kidney disease progression

Colorado Springs Gazette 28 Jan 2025
(Reuters) -Novo Nordisk said on Tuesday the U.S. FDA has approved its blockbuster drug Ozempic to lower the risk of progression of chronic kidney disease and the organ's failure, and death due to heart problems in adults with type 2 ....
Edit

FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding ...

CNBC 28 Jan 2025
Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function ... .
Edit

Quartz Is Publishing AI-Generated Articles Based on Other AI Slop, Along With Warning They May ...

Futurism 28 Jan 2025
Consider an article published today by Quartz's AI, titled "Ozempic maker Novo Nordisk will cap insulin prices to settle a lawsuit."At the top of the article, the publication's "Intelligence Newsroom" ...
Edit

NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit with the Schall Law Firm

PR Newswire 28 Jan 2025
28, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Novo Nordisk A/S ("Novo" or "the Company") (NYSE.
Edit

Novo Nordisk found in breach of transparency standards by PMCPA (University of Bath)

Public Technologies 28 Jan 2025
£1,244,027 in undisclosed payments to healthcare and patient organisations, with £635,000 of these not identified in Novo Nordisk's own internal review ... Novo Nordisk is still unsure about the total ...
Edit

Here’s my surprise prediction for the stock market in 2025 — and pessimists worldwide should ...

New York Post 28 Jan 2025
Last month, during the thick of the holidays, I found myself in a rare though not totally unprecedented predicament ... And if you look at specific European countries you will see it broadly spread except Denmark (which is mostly Novo Nordisk weakness).
Edit

Novo Nordisk agrees to cap insulin price, give drug for free to neediest Minnesotans

Post Bulletin 27 Jan 2025
Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest insulin makers of charging astronomically high prices for the diabetes drug.
Edit

Novo Nordisk successfully completes phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity

Pharmiweb 27 Jan 2025
Bagsværd, Denmark, 24 January 2025 – Novo Nordisk today announced topline results from a phase 1b/2a clinical trial with amycretin, a unimolecular GLP-1 and amylin receptor agonist intended for once weekly subcutaneous administration.
Edit

NVO INVESTOR ALERT: Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class ...

Victoria Advocate 27 Jan 2025
SAN DIEGO, Jan. 27, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Novo Nordisk A/S (NYSE. NVO) securities between November 2, 2022 and December 19, 2024, both dates inclusive ....
Edit

AG Ellison settles with Novo Nordisk to cap out-of-pocket payments for insulin at $35 a month

MinnPost 27 Jan 2025
The agreement requires Denmark-based manufacturer Novo Nordisk to cap monthly out-of-pocket payments for insulin at $35 a month for the next five years, even for people without health insurance ... Via Bring Me the News ... .

Most Viewed

×